Turtle Creek Wealth Advisors LLC Invests $41,000 in Waters Co. (NYSE:WAT)

Turtle Creek Wealth Advisors LLC purchased a new position in shares of Waters Co. (NYSE:WAT) during the fourth quarter, Holdings Channel.com reports. The fund purchased 126 shares of the medical instruments supplier’s stock, valued at approximately $41,000.

A number of other large investors have also recently bought and sold shares of the company. IMPACTfolio LLC lifted its holdings in Waters by 4.2% in the fourth quarter. IMPACTfolio LLC now owns 803 shares of the medical instruments supplier’s stock valued at $264,000 after acquiring an additional 32 shares during the period. Private Trust Co. NA increased its position in shares of Waters by 55.3% during the third quarter. Private Trust Co. NA now owns 118 shares of the medical instruments supplier’s stock worth $32,000 after purchasing an additional 42 shares in the last quarter. Summit Trail Advisors LLC increased its position in shares of Waters by 3.9% during the third quarter. Summit Trail Advisors LLC now owns 1,180 shares of the medical instruments supplier’s stock worth $324,000 after purchasing an additional 44 shares in the last quarter. IFP Advisors Inc increased its position in shares of Waters by 35.2% during the third quarter. IFP Advisors Inc now owns 173 shares of the medical instruments supplier’s stock worth $47,000 after purchasing an additional 45 shares in the last quarter. Finally, Wetherby Asset Management Inc. grew its holdings in Waters by 2.9% in the 1st quarter. Wetherby Asset Management Inc. now owns 1,645 shares of the medical instruments supplier’s stock valued at $511,000 after buying an additional 46 shares in the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Insider Transactions at Waters

In other news, Director Linda Baddour sold 500 shares of the company’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $355.54, for a total value of $177,770.00. Following the completion of the sale, the director now owns 2,250 shares of the company’s stock, valued at $799,965. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.98% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on WAT. Evercore ISI upped their target price on Waters from $320.00 to $340.00 and gave the company an “in-line” rating in a report on Thursday, April 4th. Barclays upped their target price on Waters from $275.00 to $300.00 and gave the company an “underweight” rating in a report on Monday, February 12th. Finally, Stifel Nicolaus increased their price target on Waters from $290.00 to $330.00 and gave the stock a “hold” rating in a report on Wednesday, February 7th. One research analyst has rated the stock with a sell rating and eight have given a hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $298.67.

Waters Stock Performance

NYSE WAT opened at $337.80 on Friday. The stock has a market cap of $20.00 billion, a price-to-earnings ratio of 31.13, a price-to-earnings-growth ratio of 6.71 and a beta of 0.92. The company has a quick ratio of 1.57, a current ratio of 2.22 and a debt-to-equity ratio of 2.00. Waters Co. has a fifty-two week low of $231.90 and a fifty-two week high of $363.80. The business has a fifty day moving average of $337.85 and a 200-day moving average of $304.04.

Waters (NYSE:WAT) last announced its quarterly earnings data on Tuesday, February 6th. The medical instruments supplier reported $3.62 EPS for the quarter, beating analysts’ consensus estimates of $3.56 by $0.06. Waters had a return on equity of 81.30% and a net margin of 21.72%. The business had revenue of $819.50 million during the quarter, compared to the consensus estimate of $815.50 million. During the same quarter in the previous year, the business earned $3.84 earnings per share. The business’s revenue for the quarter was down 4.5% on a year-over-year basis. As a group, analysts predict that Waters Co. will post 11.89 earnings per share for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.